stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Return on assets
Progyny, Inc.'s return on assets over the twelve months to 30 September 2026 was 12.4%, up 3.7 percentage points from fiscal 2025 (8.67%). Over the past ten years it has ranged from −35.3% (fiscal 2017) to 23.0% (fiscal 2020); the current reading is higher than 67% of that period. That is above the Healthcare Plans industry median of 3.11% and above the Healthcare sector median of −29.5%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 8.67% | 0.70 |
| FY2024 | 7.97% | (1.58) |
| FY2023 | 9.55% | 2.81 |
| FY2022 | 6.74% | (14.75) |
| FY2021 | 21.5% | (1.49) |
| FY2020 | 23.0% | 31.92 |
| FY2019 | −8.94% | (10.67) |
| FY2018 | 1.73% | 37.04 |
| FY2017 | −35.3% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| PGNY Progyny, Inc. | 12.4% |
| OSCR Oscar Health, Inc. compare | 10.9% |
| ELV Elevance Health, Inc. compare | 4.10% |
| CI Cigna Group compare | 3.80% |
| ALHC Alignment Healthcare, Inc. compare | 2.41% |
| HUM Humana Inc. compare | 2.33% |
| CLOV Clover Health Investments, Corp. compare | 1.90% |
| CNC Centene Corporation compare | 1.81% |
| MOH Molina Healthcare, Inc compare | −0.31% |
| Healthcare Plans industry median | 3.11% |
| Healthcare sector median | −29.5% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement